Steven Cohen’s Apellis Pharmaceuticals APLS Stock Holding History

Steven Cohen’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-75,000	Closed	-$2.47M	–	1078
2021 Q3	$2.47M	Buy	+75,000	New	+$4.21M	0.01%	770

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Steven Cohen's APLS Position: Q2 2026 in Review

Steven Cohen sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 4,183,918 shares — an estimated $168M sold.

Steven Cohen first reported a position in APLS in Q4 2018 and held it in 15 quarters. The position peaked at $168M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Steven Cohen reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Steven Cohen sold 4,183,918 Apellis Pharmaceuticals shares in Q2 2026, an estimated $168M.
Steven Cohen first reported a position in Apellis Pharmaceuticals in Q4 2018 and held it in 15 quarters.
Steven Cohen's Apellis Pharmaceuticals position peaked at $168M in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.